V
Vivos Therapeutics, Inc. (VVOS)
NCM – Real Time Price. Currency in USD
1.15
-0.04 (-3.36%)
At close: Mar 27, 2026, 4:00 PM EDT
1.18
+0.03 (2.44%)
After-hours: Mar 27, 2026, 6:11 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
1.15
-0.04 (-3.36%)
At close: Mar 27, 2026, 4:00 PM EDT
1.18
+0.03 (2.44%)
After-hours: Mar 27, 2026, 6:11 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.78 | 3.40 | 5.0 | |
| Quick ratio | 0.78 | 2.52 | 5.0 | |
| Debt to Equity | 4.94 | 1.11 | 2.0 | |
| Debt to Assets | 0.49 | 1.58 | 5.0 | |
| Interest coverage | N/A | 4.33 | 1.0 | |
| Weighted average score | 3.6 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 17M | 16M | 14M | 15M | 17M |
| Gross Profit | 12M | 9M | 8M | 8M | 9M |
| Operating Income | -19M | -25M | -17M | -11M | -16M |
| Net Income | -20M | -24M | -14M | -11M | -17M |
| EBITDA | -19M | -24M | -17M | -11M | -15M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 91.75 | -220.73 | 5.5 |
| Next quarter | 148.67 | 0 | 5.5 |
| Current year | 37.78 | 12.16 | 8.5 |
| Next year | 49.77 | 34.36 | 10 |
| Weighted average score | 7.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 77.57 | -7.71 | 10.91 | 4.38 | 5.5 |
| Y/Y | 75.73 | -106.41 | -22.49 | 6.87 | 4.3 |
| 3y average | -3.34 | 14.51 | 42.97 | 6.91 | 6.0 |
| 5y average | 6.77 | -6.31 | 34.04 | -39.39 | 4.3 |
| Weighted average score | 5.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $12.5M significantly exceeds cash reserves ($3.1M), raising financial stability concerns
Total current liabilities $7.4M surpass Total current assets $5.8M, signaling liquidity issues
Debt-to-equity ratio (4.9) far exceeds the industry average, reflecting over-leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.1M limits the company's ability to reinvest or pay down debt